LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 49

Search options

  1. Article ; Online: Synthetic Strategies toward Lysergic Acid Diethylamide: Ergoline Synthesis via α-Arylation, Borrowing Hydrogen Alkylation, and C-H Insertion.

    Tuck, Jeremy R / Dunlap, Lee E / Olson, David E

    The Journal of organic chemistry

    2023  Volume 88, Issue 19, Page(s) 13712–13719

    Abstract: Lysergic acid diethylamide (LSD), a semisynthetic ergoline alkaloid analogue and hallucinogen, is a potent psychoplastogen with promising therapeutic potential. While a variety of synthetic strategies for accessing ergoline alkaloids have emerged, the ... ...

    Abstract Lysergic acid diethylamide (LSD), a semisynthetic ergoline alkaloid analogue and hallucinogen, is a potent psychoplastogen with promising therapeutic potential. While a variety of synthetic strategies for accessing ergoline alkaloids have emerged, the complexity of the tetracyclic ring system results in distinct challenges in preparing analogues with novel substitution patterns. Methods of modulating the hallucinogenic activity of LSD by functionalization at previously inaccessible positions are of continued interest, and efficient syntheses of the ergoline scaffold are integral toward this purpose. Here, we report novel C-C bond forming strategies for preparing the ergoline tetracyclic core, focusing on the relatively unexplored strategy of bridging the B- and D-ring systems last. Following cross-coupling to first join the A- and D-rings, we explored a variety of methods for establishing the C-ring, including intramolecular α-arylation, borrowing hydrogen alkylation, and rhodium-catalyzed C-H insertion. Our results led to a seven-step formal synthesis of LSD and the first methods for readily introducing substitution on the C-ring. These strategies are efficient for forming ergoline-like tetracyclic compounds and analogues, though they each face unique challenges associated with elaboration to ergoline natural products. Taken together, these studies provide important insights that will guide future synthetic strategies toward ergolines.
    MeSH term(s) Ergolines ; Lysergic Acid Diethylamide ; Hydrogen/chemistry ; Alkaloids ; Alkylation
    Chemical Substances Ergolines ; Lysergic Acid Diethylamide (8NA5SWF92O) ; Hydrogen (7YNJ3PO35Z) ; Alkaloids
    Language English
    Publishing date 2023-09-11
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 123490-0
    ISSN 1520-6904 ; 0022-3263
    ISSN (online) 1520-6904
    ISSN 0022-3263
    DOI 10.1021/acs.joc.3c01363
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Reaction of

    Dunlap, Lee E / Olson, David E

    ACS omega

    2018  Volume 3, Issue 5, Page(s) 4968–4973

    Abstract: A large number of clinically used drugs and experimental pharmaceuticals possess ... ...

    Abstract A large number of clinically used drugs and experimental pharmaceuticals possess the
    Language English
    Publishing date 2018-05-07
    Publishing country United States
    Document type Journal Article
    ISSN 2470-1343
    ISSN 2470-1343
    DOI 10.1021/acsomega.8b00507
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Developmental Neurotoxicity Screen of Psychedelics and Other Drugs of Abuse in Larval Zebrafish (

    Tombari, Robert J / Mundy, Paige C / Morales, Kelly M / Dunlap, Lee E / Olson, David E / Lein, Pamela J

    ACS chemical neuroscience

    2023  Volume 14, Issue 5, Page(s) 875–884

    Abstract: In recent years, psychedelics have garnered significant interest as therapeutic agents for treating diverse neuropsychiatric disorders. However, the potential for these compounds to produce developmental neurotoxicity has not been rigorously assessed, ... ...

    Abstract In recent years, psychedelics have garnered significant interest as therapeutic agents for treating diverse neuropsychiatric disorders. However, the potential for these compounds to produce developmental neurotoxicity has not been rigorously assessed, and much of the available safety data is based on epidemiological studies with limited experimental testing in laboratory animal models. Moreover, the experimental safety data available thus far have focused on adult organisms, and the few studies conducted using developing organisms have tested a limited number of compounds, precluding direct comparisons between various chemical scaffolds. In the present study, 13 psychoactive compounds of different chemical or pharmacological classes were screened in a larval zebrafish model for teratological and behavioral abnormalities following acute and chronic developmental exposures. We found that the psychedelic tryptamines and ketamine were less neurotoxic to larval zebrafish than LSD and psychostimulants. Our work, which leverages the advantage of using zebrafish for higher throughput toxicity screening, provides a robust reference database for comparing the neurotoxicity profiles of novel psychedelics currently under development for therapeutic applications.
    MeSH term(s) Animals ; Hallucinogens/toxicity ; Zebrafish ; Larva ; Ketamine ; Models, Animal
    Chemical Substances Hallucinogens ; Ketamine (690G0D6V8H)
    Language English
    Publishing date 2023-02-08
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ISSN 1948-7193
    ISSN (online) 1948-7193
    DOI 10.1021/acschemneuro.2c00642
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: A mouse model of Zhu-Tokita-Takenouchi-Kim syndrome reveals indispensable SON functions in organ development and hematopoiesis.

    Vukadin, Lana / Park, Bohye / Mohamed, Mostafa / Li, Huashi / Elkholy, Amr / Torrelli-Diljohn, Alex / Kim, Jung-Hyun / Jeong, Kyuho / Murphy, James M / Harvey, Caitlin A / Dunlap, Sophia / Gehrs, Leah / Lee, Hanna / Kim, Hyung-Gyoon / Sah, Jay Prakash / Lee, Seth N / Stanford, Denise / Barrington, Robert A / Foote, Jeremy B /
    Sorace, Anna G / Welner, Robert S / Hildreth, Blake E / Lim, Ssang-Taek Steve / Ahn, Eun-Young Erin

    JCI insight

    2024  Volume 9, Issue 5

    Abstract: Rare diseases are underrepresented in biomedical research, leading to insufficient awareness. Zhu-Tokita-Takenouchi-Kim (ZTTK) syndrome is a rare disease caused by genetic alterations that result in heterozygous loss of function of SON. While patients ... ...

    Abstract Rare diseases are underrepresented in biomedical research, leading to insufficient awareness. Zhu-Tokita-Takenouchi-Kim (ZTTK) syndrome is a rare disease caused by genetic alterations that result in heterozygous loss of function of SON. While patients with ZTTK syndrome live with numerous symptoms, the lack of model organisms hampers our understanding of SON and this complex syndrome. Here, we developed Son haploinsufficiency (Son+/-) mice as a model of ZTTK syndrome and identified the indispensable roles of Son in organ development and hematopoiesis. Son+/- mice recapitulated clinical symptoms of ZTTK syndrome, including growth retardation, cognitive impairment, skeletal abnormalities, and kidney agenesis. Furthermore, we identified hematopoietic abnormalities in Son+/- mice, including leukopenia and immunoglobulin deficiency, similar to those observed in human patients. Surface marker analyses and single-cell transcriptome profiling of hematopoietic stem and progenitor cells revealed that Son haploinsufficiency shifted cell fate more toward the myeloid lineage but compromised lymphoid lineage development by reducing genes required for lymphoid and B cell lineage specification. Additionally, Son haploinsufficiency caused inappropriate activation of erythroid genes and impaired erythropoiesis. These findings highlight the importance of the full gene expression of Son in multiple organs. Our model serves as an invaluable research tool for this rare disease and related disorders associated with SON dysfunction.
    MeSH term(s) Animals ; Humans ; Mice ; Gene Expression Profiling ; Hematopoiesis/genetics ; Mutation ; Rare Diseases
    Chemical Substances Son protein, mouse
    Language English
    Publishing date 2024-03-08
    Publishing country United States
    Document type Journal Article
    ISSN 2379-3708
    ISSN (online) 2379-3708
    DOI 10.1172/jci.insight.175053
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Two-Year Tumor Outcomes of a Phase 2B, Randomized, Double-Blind Trial of Avasopasem Manganese (GC4419) Versus Placebo to Reduce Severe Oral Mucositis Owing to Concurrent Radiation Therapy and Cisplatin for Head and Neck Cancer.

    Anderson, Carryn M / Lee, Christopher M / Saunders, Deborah / Curtis, Amarinthia E / Dunlap, Neal E / Nangia, Chaitali / Lee, Arielle S / Kovoor, Philip / Bar-Ad, Voichita / Pedadda, Abhinand V / Holmlund, Jon / Downs, Matt / Sonis, Stephen T

    International journal of radiation oncology, biology, physics

    2022  Volume 114, Issue 3, Page(s) 416–421

    Abstract: Purpose: Avasopasem manganese (GC4419), an investigational selective dismutase mimetic radioprotector, reduced duration, incidence, and severity of severe oral mucositis (World Health Organization grade 3-4) in a phase 2b, randomized, double-blind trial ...

    Abstract Purpose: Avasopasem manganese (GC4419), an investigational selective dismutase mimetic radioprotector, reduced duration, incidence, and severity of severe oral mucositis (World Health Organization grade 3-4) in a phase 2b, randomized, double-blind trial of patients receiving concurrent cisplatin (cis) and radiation therapy (RT) for head and neck cancer. We report the secondary endpoints of final 1- and 2-year tumor outcomes and exploratory data on trismus and xerostomia.
    Methods and materials: Patients with locally advanced oral cavity or oropharynx cancer to be treated with definitive or postop cis and RT were randomized to 1 of 3 arms: 30 mg avasopasem, 90 mg avasopasem, or placebo. Pairwise comparisons of Kaplan-Meier estimates (each active arm separately vs placebo) were made for overall survival, progression-free survival, locoregional control, and distant metastasis-free survival. Xerostomia and trismus data were collected at each follow-up visit and analyzed for trends by post-RT timepoint and treatment group.
    Results: At a median follow-up for the entire cohort of 25.5 months (25th-75th percentile, 24.6-26.2 months; range, 0.2-31.9 months), Kaplan-Meier estimates of 1- and 2-year overall survival, progression-free survival, locoregional control, and distant metastasis-free survival were not statistically different. No trends were apparent in xerostomia or trismus data.
    Conclusions: Avasopasem does not lead to statistically different tumor control outcomes when used concurrently with cis and RT for head and neck cancer. There was no detectable effect on trismus or xerostomia.
    MeSH term(s) Cisplatin/adverse effects ; Head and Neck Neoplasms/drug therapy ; Head and Neck Neoplasms/radiotherapy ; Humans ; Organometallic Compounds ; Stomatitis/etiology ; Stomatitis/prevention & control ; Trismus/etiology ; Trismus/prevention & control ; Xerostomia/etiology ; Xerostomia/prevention & control
    Chemical Substances Organometallic Compounds ; avasopasem manganese (EY1WA413UL) ; Cisplatin (Q20Q21Q62J)
    Language English
    Publishing date 2022-06-17
    Publishing country United States
    Document type Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 197614-x
    ISSN 1879-355X ; 0360-3016
    ISSN (online) 1879-355X
    ISSN 0360-3016
    DOI 10.1016/j.ijrobp.2022.06.063
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.

    Dunlap, Lee E / Andrews, Anne M / Olson, David E

    ACS chemical neuroscience

    2018  Volume 9, Issue 10, Page(s) 2408–2427

    Abstract: Better known as "ecstasy", 3,4-methylenedioxymethamphetamine (MDMA) is a small molecule that has played a prominent role in defining the ethos of today's teenagers and young adults, much like lysergic acid diethylamide (LSD) did in the 1960s. Though MDMA ...

    Abstract Better known as "ecstasy", 3,4-methylenedioxymethamphetamine (MDMA) is a small molecule that has played a prominent role in defining the ethos of today's teenagers and young adults, much like lysergic acid diethylamide (LSD) did in the 1960s. Though MDMA possesses structural similarities to compounds like amphetamine and mescaline, it produces subjective effects that are unlike any of the classical psychostimulants or hallucinogens and is one of the few compounds capable of reliably producing prosocial behavioral states. As a result, MDMA has captured the attention of recreational users, the media, artists, psychiatrists, and neuropharmacologists alike. Here, we detail the synthesis of MDMA as well as its pharmacology, metabolism, adverse effects, and potential use in medicine. Finally, we discuss its history and why it is perhaps the most important compound for the future of psychedelic science-having the potential to either facilitate new psychedelic research initiatives, or to usher in a second Dark Age for the field.
    MeSH term(s) Hallucinogens/chemistry ; Hallucinogens/history ; Hallucinogens/pharmacology ; Hallucinogens/therapeutic use ; History, 20th Century ; History, 21st Century ; Humans ; N-Methyl-3,4-methylenedioxyamphetamine/chemistry ; N-Methyl-3,4-methylenedioxyamphetamine/history ; N-Methyl-3,4-methylenedioxyamphetamine/pharmacology ; N-Methyl-3,4-methylenedioxyamphetamine/therapeutic use
    Chemical Substances Hallucinogens ; N-Methyl-3,4-methylenedioxyamphetamine (KE1SEN21RM)
    Language English
    Publishing date 2018-07-12
    Publishing country United States
    Document type Historical Article ; Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ISSN 1948-7193
    ISSN (online) 1948-7193
    DOI 10.1021/acschemneuro.8b00155
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Medical Societies Must Choose Professional Meeting Locations Responsibly in a Post-

    Lee, Alison G / Maley, Jason / Hibbert, Kathryn / Akgün, Kathleen M / Hauschildt, Katrina E / Law, Anica / Kaminski, Naftali / Hayes, Margaret / Gesthalter, Yaron / Bosslet, Gabriel T / Santhosh, Lekshmi / Witkin, Alison / Hills-Dunlap, Kelsey / Çoruh, Başak / Gershengorn, Hayley B / Hardin, C Corey

    Annals of the American Thoracic Society

    2023  Volume 20, Issue 6, Page(s) 781–784

    MeSH term(s) Humans ; Societies, Medical/ethics ; Supreme Court Decisions ; Congresses as Topic/ethics
    Language English
    Publishing date 2023-02-24
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2717461-X
    ISSN 2325-6621 ; 1943-5665 ; 2325-6621
    ISSN (online) 2325-6621 ; 1943-5665
    ISSN 2325-6621
    DOI 10.1513/AnnalsATS.202211-928IP
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Reaction of N,N‑Dimethyltryptamine with Dichloromethane Under Common Experimental Conditions

    Lee E. Dunlap / David E. Olson

    ACS Omega, Vol 3, Iss 5, Pp 4968-

    2018  Volume 4973

    Keywords Chemistry ; QD1-999
    Language English
    Publishing date 2018-05-01T00:00:00Z
    Publisher American Chemical Society
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article: A mouse model of ZTTK syndrome reveals indispensable SON functions in organ development and hematopoiesis.

    Vukadin, Lana / Park, Bohye / Mohamed, Mostafa / Li, Huashi / Elkholy, Amr / Torrelli-Diljohn, Alex / Kim, Jung-Hyun / Jeong, Kyuho / Murphy, James M / Harvey, Caitlin A / Dunlap, Sophia / Gehrs, Leah / Lee, Hanna / Kim, Hyung-Gyoon / Lee, Seth N / Stanford, Denise / Barrington, Robert A / Foote, Jeremy B / Sorace, Anna G /
    Welner, Robert S / Hildreth, Blake E / Lim, Ssang-Taek Steve / Ahn, Eun-Young Erin

    bioRxiv : the preprint server for biology

    2023  

    Abstract: Rare diseases are underrepresented in biomedical research, leading to insufficient awareness. Zhu-Tokita-Takenouchi-Kim (ZTTK) syndrome is a rare disease caused by genetic alterations that result in heterozygous loss-of-function of SON. While ZTTK ... ...

    Abstract Rare diseases are underrepresented in biomedical research, leading to insufficient awareness. Zhu-Tokita-Takenouchi-Kim (ZTTK) syndrome is a rare disease caused by genetic alterations that result in heterozygous loss-of-function of SON. While ZTTK syndrome patients suffer from numerous symptoms, the lack of model organisms hamper our understanding of both SON and this complex syndrome. Here, we developed
    Language English
    Publishing date 2023-11-19
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2023.11.19.567732
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Effects of N, N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression.

    Cameron, Lindsay P / Benson, Charlie J / Dunlap, Lee E / Olson, David E

    ACS chemical neuroscience

    2018  Volume 9, Issue 7, Page(s) 1582–1590

    Abstract: Depression and anxiety disorders are debilitating diseases resulting in substantial economic costs to society. Traditional antidepressants often take weeks to months to positively affect mood and are ineffective for about 30% of the population. ... ...

    Abstract Depression and anxiety disorders are debilitating diseases resulting in substantial economic costs to society. Traditional antidepressants often take weeks to months to positively affect mood and are ineffective for about 30% of the population. Alternatives, such as ketamine, a dissociative anesthetic capable of producing hallucinations, and the psychoactive tisane ayahuasca, have shown great promise due to their fast-acting nature and effectiveness in treatment-resistant populations. Here, we investigate the effects of N, N-dimethyltryptamine (DMT), the principle hallucinogenic component of ayahuasca, in rodent behavioral assays relevant to anxiety and depression using adult, male, Sprague-Dawley rats. We find that while DMT elicits initial anxiogenic responses in several of these paradigms, its long-lasting effects tend to reduce anxiety by facilitating the extinction of cued fear memory. Furthermore, DMT reduces immobility in the forced swim test, which is a characteristic behavioral response induced by many antidepressants. Our results demonstrate that DMT produces antidepressant and anxiolytic behavioral effects in rodents, warranting further investigation of ayahuasca and classical psychedelics as treatments for depression and post-traumatic stress disorder.
    MeSH term(s) Animals ; Anti-Anxiety Agents/pharmacology ; Antidepressive Agents/pharmacology ; Anxiety Disorders/drug therapy ; Conditioning, Psychological/drug effects ; Depressive Disorder/drug therapy ; Disease Models, Animal ; Exploratory Behavior/drug effects ; Fear/drug effects ; Feeding Behavior/drug effects ; Male ; Motor Activity/drug effects ; N,N-Dimethyltryptamine/pharmacology ; Rats, Inbred SHR
    Chemical Substances Anti-Anxiety Agents ; Antidepressive Agents ; N,N-Dimethyltryptamine (WUB601BHAA)
    Language English
    Publishing date 2018-04-24
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ISSN 1948-7193
    ISSN (online) 1948-7193
    DOI 10.1021/acschemneuro.8b00134
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top